Tesileanu CMS, Sanson M, Wick W, Brandes AA, et al. Temozolomide and radiotherapy versus radiotherapy alone in patients with glioblastoma, IDH-wildtype: post-hoc analysis of the EORTC randomized phase 3 CATNON trial. Clin Cancer Res 2022 Mar 11. pii: 682153. doi: 10.1158/1078-0432.CCR-21-4283.
PMID: 35275197